Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Iridex Cp (IRIX)

Iridex Cp (IRIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,913
  • Shares Outstanding, K 13,898
  • Annual Sales, $ 43,450 K
  • Annual Income, $ -8,810 K
  • 60-Month Beta 1.20
  • Price/Sales 2.22
  • Price/Cash Flow N/A
  • Price/Book 4.45
Trade IRIX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.12
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.60 +259.38%
on 12/21/20
6.25 -8.00%
on 01/15/21
+4.06 (+240.24%)
since 12/15/20
3-Month
1.60 +259.38%
on 12/21/20
6.25 -8.00%
on 01/15/21
+3.84 (+200.26%)
since 10/15/20
52-Week
1.22 +371.31%
on 04/03/20
6.25 -8.00%
on 01/15/21
+2.28 (+65.71%)
since 01/15/20

Most Recent Stories

More News
IRIDEX Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2020

IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year ended January 2, 2021.

IRIX : 5.75 (+3.98%)
Thinking about buying stock in Immersion Corp, IRIDEX Corp, One Stop Systems, Phio Pharmaceuticals, or Alkermes?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IMMR, IRIX, OSS, PHIO, and ALKS.

ALKS : 22.37 (+1.68%)
IMMR : 12.67 (+1.77%)
IRIX : 5.75 (+3.98%)
OSS : 4.75 (-4.04%)
PHIO : 2.91 (-2.68%)
IRIDEX Announces MicroPulse Transscleral Laser Therapy Now Accepted in the European Glaucoma Society Guidelines

IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, reports that MicroPulse Transscleral Laser Therapy...

IRIX : 5.75 (+3.98%)
Global Ophthalmic Lasers Market 2020 Research Report with COVID-19 Impact, by Future Trend, Growth rate and Industry Analysis to 2026

has newly published research study entitled that incorporates the analysis of different factors that extends the market’s growth. The report assists with breaking down top makers, districts, and in...

IRIX : 5.75 (+3.98%)
NVS : 95.63 (+1.07%)
QUTEF : 12.8966 (+18.32%)
VRX.TO : 30.80 (-3.33%)
Global Ophthalmic Laser Devices Market 2020 Industry Size, Share, Growth, Outlook, Segmentation, Comprehensive Analysis by 2026

offers end to end industry from the definition, product specifications, and demand till forecast prospects. The report studies the industry coverage, current market status, and market outlook and forecast...

CZMWF : 133.2000 (-0.22%)
ELXMF : 0.2950 (+47.50%)
IRIX : 5.75 (+3.98%)
NVS : 95.63 (+1.07%)
QUTEF : 12.8966 (+18.32%)
VRX.TO : 30.80 (-3.33%)
Iridex (IRIX) Reports Q3 Loss, Tops Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of 33.33% and 13.08%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

IRIX : 5.75 (+3.98%)
Iridex: 3Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Monday reported a loss of $1.7 million in its third quarter.

IRIX : 5.75 (+3.98%)
IRIDEX Announces Third Quarter 2020 Financial Results

IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 26, 2020.

IRIX : 5.75 (+3.98%)
IRIDEX Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 9, 2020 / IRIDEX Corp. (NASDAQ:IRIX) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 9, 2020 at 5:00 PM Eastern...

IRIX : 5.75 (+3.98%)
IRIDEX to Present at the 2020 Stifel Virtual Healthcare Conference

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Virtual Healthcare Conference.

IRIX : 5.75 (+3.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors....

See More

Key Turning Points

3rd Resistance Point 7.20
2nd Resistance Point 6.72
1st Resistance Point 6.24
Last Price 5.75
1st Support Level 5.28
2nd Support Level 4.80
3rd Support Level 4.32

See More

52-Week High 6.25
Last Price 5.75
Fibonacci 61.8% 4.33
Fibonacci 50% 3.74
Fibonacci 38.2% 3.14
52-Week Low 1.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar